# xCures Inc.

> xCures is an AI-powered health-data platform that automatically retrieves medical records from any care site in the United States, then structures, normalizes, and validates that messy, unstructured data into searchable, source-traceable clinical insights. Born in oncology, it generates regulatory-grade real-world evidence, AI-built clinical checklists, and natural-language patient summaries that help researchers, biopharma, advocacy groups, and clinicians understand each patient's full medical journey - and run continuously learning 'virtual trials' across all patients, all treatments, all the time.

- **Founded:** 2018
- **Headquarters:** Oakland, California, United States
- **Founders:** Marty Tenenbaum (Co-Founder & Chairman), Jeff Shrager (Co-Founder & Director of Research), Mika Newton (CEO)
- **Team size:** ~51 employees
- **Products:** xCures Platform, AI-Powered Clinical Checklists, Natural-Language Patient Summaries / Cancer Journey, xDECIDE, Clinical Data Extraction as a Service
- **Notable:** Raised $12.69M Series A led by Boehringer Ingelheim Venture Fund (2021), Granted a USPTO patent for AI technology enabling virtual trials and continuous learning (2024), Became a Qualified Health Information Network (QHIN) participant (2024)

## Products & services

- **xCures Platform** — A real-time health-data platform that automatically retrieves medical records from any US care site, then normalizes and structures them into a searchable database.
- **AI-Powered Clinical Checklists** — AI auto-extracts source-verifiable, configurable clinical checklists from records; version 2.0 (Oct 2025) lets partners rapidly design and deploy checklists with full traceability.
- **Natural-Language Patient Summaries / Cancer Journey** — AI-generated, source-linked patient summaries that surface each patient's full medical journey for clinicians and researchers.
- **xDECIDE** — A clinical decision-support tool that helps oncologists identify personalized treatment options for advanced cancer patients.
- **Clinical Data Extraction as a Service** — Available via AWS Marketplace; medical-record structuring and extraction offered as a service to researchers and biopharma.

## Achievements

- Raised $12.69M Series A led by Boehringer Ingelheim Venture Fund (2021)
- Granted a USPTO patent for AI technology enabling virtual trials and continuous learning (2024)
- Became a Qualified Health Information Network (QHIN) participant (2024)
- Achieved HITRUST e1 certification for cybersecurity controls (2025)
- Achieved a fully functional Individual Access Services (IAS) solution under TEFCA (2025)
- Featured by the White House Cancer Moonshot for its DMG/DIPG natural history study
- Served 1,000+ advanced cancer patients on the platform by 2021

## Latest updates

- **2026-03** — Partnered with careMESH to expand interoperability and connect structured clinical data with EHR workflows.
- **2026-02** — Collaborated with the Colorectal Cancer Alliance to support patient access to medical records through BlueHQ.
- **2025-12** — Partnered with NeoGenomics for clinical data access via HIE and QHIN integration.
- **2025-10** — Launched AI-Powered Clinical Checklists 2.0 with full source traceability.
- **2025-08** — Achieved a fully functional Individual Access Services solution under TEFCA.
- **2025-05** — Achieved HITRUST e1 certification and joined Civitas Networks for Health.

## Links

- Website: https://xcures.com
- LinkedIn: http://www.linkedin.com/company/xcures
- Twitter/X: https://twitter.com/xcures_platform
- Instagram: https://www.instagram.com/xcures.platform/
- Facebook: https://www.facebook.com/xcures.platform/

---

Profile page: https://yespress.io/xcures-inc
Published by YesPress — https://yespress.io
Last updated: 2026-06-11